NVCR (STOCKS)
NovoCure Limited Ordinary Shares
$11.229900
+0.509900 (+4.76%)
Prev close: $10.720000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Frank Leonard
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,277.90M
- Employees
- 1,488
- P/E (TTM)
- -8.77
- P/B (TTM)
- 3.54
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
6
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.22 | $-0.42 | +0.1997 | +47.58% |
|
Sep 2025 (Q3)
|
$-0.33 | $-0.43 | +0.0994 | +23.15% |
|
Jun 2025 (Q2)
|
$-0.36 | $-0.39 | +0.0318 | +8.12% |
|
Mar 2025 (Q1)
|
$-0.31 | $-0.47 | +0.1636 | +34.54% |
Financial Statements
| Revenues | $655.35M |
| Benefits Costs and Expenses | $791.60M |
| Cost Of Revenue | $166.88M |
| Costs And Expenses | $791.60M |
| Gross Profit | $488.47M |
| Operating Expenses | $642.27M |
| Depreciation and Amortization | $14.65M |
| Research and Development | $224.54M |
| Other Operating Expenses | $403.08M |
| Operating Income/Loss | -$153.80M |
| Income/Loss From Continuing Operations After Tax | -$136.23M |
| Income/Loss From Continuing Operations Before Tax | -$136.25M |
| Income Tax Expense/Benefit | -$23.00K |
| Income Tax Expense/Benefit, Current | -$23.00K |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Interest Expense, Operating | $22.22M |
| Net Income/Loss | -$136.23M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$136.23M |
| Net Income/Loss Available To Common Stockholders, Basic | -$136.23M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.22 |
| Diluted Earnings Per Share | -$1.22 |
| Basic Average Shares | 111,471,991 |
| Diluted Average Shares | 111,471,991 |
| Assets | $804.33M |
| Current Assets | $646.73M |
| Inventory | $41.11M |
| Prepaid Expenses | $9.66M |
| Other Current Assets | $595.96M |
| Noncurrent Assets | $157.60M |
| Fixed Assets | $77.61M |
| Other Non-current Assets | $79.99M |
| Liabilities | $463.86M |
| Current Liabilities | $223.23M |
| Wages | $64.36M |
| Other Current Liabilities | $158.86M |
| Noncurrent Liabilities | $240.63M |
| Equity | $340.47M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $340.47M |
| Liabilities And Equity | $804.33M |
| Net Cash Flow From Operating Activities | -$49.03M |
| Net Cash Flow From Operating Activities, Continuing | -$49.03M |
| Net Cash Flow From Investing Activities | $437.28M |
| Net Cash Flow From Investing Activities, Continuing | $437.28M |
| Net Cash Flow From Financing Activities | -$451.34M |
| Net Cash Flow From Financing Activities, Continuing | -$451.34M |
| Exchange Gains/Losses | $394.00K |
| Net Cash Flow | -$62.70M |
| Net Cash Flow, Continuing | -$63.10M |
| Comprehensive Income/Loss | -$134.17M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$134.17M |
| Other Comprehensive Income/Loss | $2.06M |